Australia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.14 (1.94 - 2.34) 2019 Modelled IHME
2.23 (1.99 - 2.44) 2018 Modelled IHME
2.27 (2 - 2.56) 2017 Modelled IHME
2.27 (2.04 - 2.53) 2016 Modelled IHME
2.27 (2.03 - 2.53) 2015 Modelled IHME
2.28 (2.06 - 2.52) 2014 Modelled IHME
2.31 (2.10 - 2.53) 2013 Modelled IHME
2.33 (2.12 - 2.55) 2012 Modelled IHME
2.36 (2.15 - 2.59) 2011 Modelled IHME
2.39 (2.18 - 2.63) 2010 Modelled IHME
2.42 (2.21 - 2.64) 2009 Modelled IHME
2.44 (2.23 - 2.65) 2008 Modelled IHME
2.47 (2.25 - 2.68) 2007 Modelled IHME
2.5 (2.27 - 2.72) 2006 Modelled IHME
2.52 (2.28 - 2.76) 2005 Modelled IHME
2.55 (2.31 - 2.77) 2004 Modelled IHME
2.57 (2.34 - 2.79) 2003 Modelled IHME
2.59 (2.36 - 2.81) 2002 Modelled IHME
2.62 (2.38 - 2.86) 2001 Modelled IHME
2.63 (2.39 - 2.89) 2000 Modelled IHME
2.65 (2.42 - 2.90) 1999 Modelled IHME
2.67 (2.45 - 2.91) 1998 Modelled IHME
2.69 (2.46 - 2.93) 1997 Modelled IHME
2.71 (2.45 - 2.96) 1996 Modelled IHME
2.72 (2.45 - 2.99) 1995 Modelled IHME
2.73 (2.48 - 2.99) 1994 Modelled IHME
2.74 (2.50 - 3.01) 1993 Modelled IHME
2.75 (2.52 - 3.02) 1992 Modelled IHME
2.76 (2.52 - 3.04) 1991 Modelled IHME
2.76 (2.50 - 3.07) 1990 Modelled IHME
0.46 (0.33 - 0.62) 2015 Modelled WHO
1 (0.90 - 1) 2016 Modelled Razavi-Shearer et al, 2018
1.01 2015 Modelled Maclachlan et al, 2018
0.37 (0.36 - 0.38) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.07 (0.06 - 0.09) 2019 Modelled IHME
0.07 (0.06 - 0.09) 2018 Modelled IHME
0.07 (0.06 - 0.09) 2017 Modelled IHME
0.08 (0.06 - 0.10) 2016 Modelled IHME
0.08 (0.06 - 0.10) 2015 Modelled IHME
0.08 (0.06 - 0.10) 2014 Modelled IHME
0.08 (0.07 - 0.10) 2013 Modelled IHME
0.08 (0.07 - 0.10) 2012 Modelled IHME
0.08 (0.07 - 0.11) 2011 Modelled IHME
0.08 (0.07 - 0.11) 2010 Modelled IHME
0.08 (0.07 - 0.11) 2009 Modelled IHME
0.08 (0.07 - 0.11) 2008 Modelled IHME
0.08 (0.07 - 0.11) 2007 Modelled IHME
0.08 (0.07 - 0.11) 2006 Modelled IHME
0.08 (0.07 - 0.11) 2005 Modelled IHME
0.09 (0.07 - 0.11) 2004 Modelled IHME
0.09 (0.07 - 0.11) 2003 Modelled IHME
0.1 (0.08 - 0.12) 2002 Modelled IHME
0.1 (0.08 - 0.13) 2001 Modelled IHME
0.12 (0.09 - 0.14) 2000 Modelled IHME
0.2 (0.16 - 0.25) 1999 Modelled IHME
0.4 (0.31 - 0.49) 1998 Modelled IHME
0.62 (0.49 - 0.78) 1997 Modelled IHME
0.82 (0.63 - 1.02) 1996 Modelled IHME
0.9 (0.70 - 1.14) 1995 Modelled IHME
0.91 (0.71 - 1.16) 1994 Modelled IHME
0.92 (0.73 - 1.17) 1993 Modelled IHME
0.93 (0.74 - 1.19) 1992 Modelled IHME
0.93 (0.74 - 1.20) 1991 Modelled IHME
0.93 (0.74 - 1.21) 1990 Modelled IHME
0.15 (0.09 - 0.23) 2015 Modelled WHO
0.4 (0 - 2.20) 2002 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
465,319 (421,570 - 517,135) 1990 Modelled IHME
470,918 (429,986 - 519,323) 1991 Modelled IHME
475,747 (435,930 - 522,076) 1992 Modelled IHME
479,914 (437,803 - 526,200) 1993 Modelled IHME
483,527 (439,239 - 529,505) 1994 Modelled IHME
486,800 (438,959 - 534,197) 1995 Modelled IHME
489,608 (443,298 - 535,290) 1996 Modelled IHME
491,843 (449,175 - 536,057) 1997 Modelled IHME
493,746 (451,511 - 538,156) 1998 Modelled IHME
495,609 (451,931 - 540,965) 1999 Modelled IHME
497,604 (452,208 - 544,996) 2000 Modelled IHME
499,647 (455,088 - 546,177) 2001 Modelled IHME
501,551 (457,132 - 544,226) 2002 Modelled IHME
503,388 (458,195 - 545,794) 2003 Modelled IHME
505,178 (458,292 - 549,741) 2004 Modelled IHME
507,042 (458,628 - 553,784) 2005 Modelled IHME
508,904 (462,158 - 553,350) 2006 Modelled IHME
510,667 (465,160 - 554,603) 2007 Modelled IHME
512,382 (467,629 - 556,078) 2008 Modelled IHME
514,167 (469,642 - 560,683) 2009 Modelled IHME
516,285 (470,914 - 568,257) 2010 Modelled IHME
518,178 (471,718 - 568,169) 2011 Modelled IHME
519,625 (472,536 - 568,855) 2012 Modelled IHME
521,336 (474,320 - 572,048) 2013 Modelled IHME
524,087 (471,767 - 577,724) 2014 Modelled IHME
528,978 (472,329 - 588,870) 2015 Modelled IHME
536,046 (481,393 - 597,539) 2016 Modelled IHME
542,809 (478,496 - 611,823) 2017 Modelled IHME
539,934 (483,091 - 591,485) 2018 Modelled IHME
525,919 (477,108 - 573,902) 2019 Modelled IHME
234,000 (222,000 - 252,000) 2016 Modelled Razavi-Shearer et al, 2018
233,947 (222,706 - 246,015) 2017 Survey/reported The Kirby Institute, 2018
230,034 (219,465 - 249,457) 2016 Survey/reported The Kirby Institute, 2017
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.19 (1.74 - 2.74) 2019 Modelled IHME
2.18 (1.74 - 2.73) 2018 Modelled IHME
2.18 (1.74 - 2.74) 2017 Modelled IHME
2.22 (1.76 - 2.78) 2016 Modelled IHME
2.27 (1.80 - 2.85) 2015 Modelled IHME
2.23 (1.77 - 2.80) 2014 Modelled IHME
2.16 (1.72 - 2.71) 2013 Modelled IHME
2.09 (1.66 - 2.62) 2012 Modelled IHME
2.07 (1.64 - 2.58) 2011 Modelled IHME
2.02 (1.60 - 2.52) 2010 Modelled IHME
2.06 (1.64 - 2.56) 2009 Modelled IHME
2.21 (1.77 - 2.73) 2008 Modelled IHME
2.36 (1.90 - 2.87) 2007 Modelled IHME
2.46 (1.99 - 2.97) 2006 Modelled IHME
2.5 (2.01 - 3.01) 2005 Modelled IHME
2.46 (1.98 - 2.98) 2004 Modelled IHME
2.42 (1.94 - 2.95) 2003 Modelled IHME
2.35 (1.89 - 2.87) 2002 Modelled IHME
2.26 (1.81 - 2.77) 2001 Modelled IHME
2.22 (1.78 - 2.72) 2000 Modelled IHME
2.19 (1.76 - 2.70) 1999 Modelled IHME
2.19 (1.77 - 2.69) 1998 Modelled IHME
2.21 (1.76 - 2.71) 1997 Modelled IHME
2.19 (1.74 - 2.69) 1996 Modelled IHME
2.15 (1.71 - 2.65) 1995 Modelled IHME
2.14 (1.69 - 2.65) 1994 Modelled IHME
2.08 (1.64 - 2.57) 1993 Modelled IHME
2.05 (1.62 - 2.55) 1992 Modelled IHME
2 (1.57 - 2.49) 1991 Modelled IHME
1.98 (1.55 - 2.47) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
537 (427 - 674) 2019 Modelled IHME
530 (422 - 663) 2018 Modelled IHME
522 (416 - 655) 2017 Modelled IHME
523 (417 - 656) 2016 Modelled IHME
527 (419 - 662) 2015 Modelled IHME
512 (407 - 642) 2014 Modelled IHME
489 (388 - 613) 2013 Modelled IHME
466 (369 - 583) 2012 Modelled IHME
454 (360 - 566) 2011 Modelled IHME
436 (345 - 544) 2010 Modelled IHME
439 (348 - 544) 2009 Modelled IHME
464 (370 - 572) 2008 Modelled IHME
488 (392 - 594) 2007 Modelled IHME
501 (405 - 605) 2006 Modelled IHME
501 (403 - 605) 2005 Modelled IHME
487 (392 - 591) 2004 Modelled IHME
475 (380 - 578) 2003 Modelled IHME
455 (365 - 554) 2002 Modelled IHME
432 (346 - 529) 2001 Modelled IHME
418 (336 - 513) 2000 Modelled IHME
410 (329 - 503) 1999 Modelled IHME
405 (326 - 496) 1998 Modelled IHME
403 (321 - 495) 1997 Modelled IHME
396 (315 - 487) 1996 Modelled IHME
385 (306 - 474) 1995 Modelled IHME
379 (299 - 468) 1994 Modelled IHME
364 (288 - 450) 1993 Modelled IHME
355 (280 - 441) 1992 Modelled IHME
342 (269 - 426) 1991 Modelled IHME
333 (262 - 417) 1990 Modelled IHME
1,634 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
12 (8 - 17) 2019 Modelled IHME
12 (8 - 17) 2018 Modelled IHME
12 (8 - 17) 2017 Modelled IHME
12 (8 - 17) 2016 Modelled IHME
12 (8 - 17) 2015 Modelled IHME
12 (9 - 18) 2014 Modelled IHME
13 (9 - 18) 2013 Modelled IHME
13 (9 - 18) 2012 Modelled IHME
13 (9 - 18) 2011 Modelled IHME
13 (9 - 18) 2010 Modelled IHME
13 (9 - 18) 2009 Modelled IHME
13 (9 - 19) 2008 Modelled IHME
13 (9 - 19) 2007 Modelled IHME
14 (10 - 19) 2006 Modelled IHME
14 (10 - 20) 2005 Modelled IHME
14 (10 - 20) 2004 Modelled IHME
14 (10 - 20) 2003 Modelled IHME
14 (10 - 20) 2002 Modelled IHME
14 (10 - 20) 2001 Modelled IHME
15 (10 - 20) 2000 Modelled IHME
15 (10 - 20) 1999 Modelled IHME
15 (10 - 20) 1998 Modelled IHME
15 (10 - 20) 1997 Modelled IHME
14 (10 - 21) 1996 Modelled IHME
15 (10 - 21) 1995 Modelled IHME
15 (10 - 21) 1994 Modelled IHME
15 (10 - 21) 1993 Modelled IHME
15 (10 - 21) 1992 Modelled IHME
15 (10 - 21) 1991 Modelled IHME
15 (10 - 21) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
94 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
91 2014 Survey/reported WHO/UNICEF
91 2013 Survey/reported WHO/UNICEF
91 2012 Survey/reported WHO/UNICEF
92 2011 Survey/reported WHO/UNICEF
92 2010 Survey/reported WHO/UNICEF
94 2009 Survey/reported WHO/UNICEF
94 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
95 2004 Survey/reported WHO/UNICEF
95 2003 Survey/reported WHO/UNICEF
95 2002 Survey/reported WHO/UNICEF
94 2001 Survey/reported WHO/UNICEF
95 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
461 (364 - 631) 2016 Survey/reported Iversen J et al, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
41.8 (39.80 - 43.90) 2015 Survey/reported Memedovic S et al, 2016
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.5 (1.18 - 1.90) 2019 Modelled IHME
1.49 (1.18 - 1.87) 2018 Modelled IHME
1.49 (1.18 - 1.88) 2017 Modelled IHME
1.51 (1.21 - 1.88) 2016 Modelled IHME
1.53 (1.22 - 1.92) 2015 Modelled IHME
1.54 (1.24 - 1.94) 2014 Modelled IHME
1.55 (1.24 - 1.94) 2013 Modelled IHME
1.56 (1.25 - 1.95) 2012 Modelled IHME
1.57 (1.26 - 1.96) 2011 Modelled IHME
1.57 (1.25 - 1.96) 2010 Modelled IHME
1.56 (1.25 - 1.96) 2009 Modelled IHME
1.55 (1.25 - 1.95) 2008 Modelled IHME
1.53 (1.23 - 1.93) 2007 Modelled IHME
1.51 (1.20 - 1.93) 2006 Modelled IHME
1.5 (1.19 - 1.92) 2005 Modelled IHME
1.51 (1.20 - 1.90) 2004 Modelled IHME
1.52 (1.22 - 1.91) 2003 Modelled IHME
1.54 (1.25 - 1.92) 2002 Modelled IHME
1.56 (1.27 - 1.93) 2001 Modelled IHME
1.57 (1.28 - 1.94) 2000 Modelled IHME
1.59 (1.31 - 1.95) 1999 Modelled IHME
1.62 (1.34 - 1.96) 1998 Modelled IHME
1.65 (1.36 - 1.99) 1997 Modelled IHME
1.67 (1.38 - 2.01) 1996 Modelled IHME
1.68 (1.37 - 2.02) 1995 Modelled IHME
1.68 (1.38 - 2.02) 1994 Modelled IHME
1.67 (1.37 - 2) 1993 Modelled IHME
1.65 (1.36 - 1.99) 1992 Modelled IHME
1.62 (1.33 - 1.98) 1991 Modelled IHME
1.59 (1.29 - 1.96) 1990 Modelled IHME
0.74 (0.52 - 0.78) 2017 Survey/reported The Kirby Institute, 2018
1 (0.70 - 1) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.7 (1.20 - 1.80) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
53.5 (50.20 - 56.90) 2014 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
267,921 (217,309 - 330,295) 1990 Modelled IHME
277,292 (227,111 - 338,312) 1991 Modelled IHME
285,194 (234,649 - 344,399) 1992 Modelled IHME
291,652 (240,420 - 350,850) 1993 Modelled IHME
296,697 (243,580 - 357,199) 1994 Modelled IHME
300,430 (245,461 - 362,054) 1995 Modelled IHME
302,052 (249,592 - 363,929) 1996 Modelled IHME
301,406 (248,554 - 364,283) 1997 Modelled IHME
299,592 (247,347 - 362,827) 1998 Modelled IHME
297,779 (244,269 - 363,971) 1999 Modelled IHME
297,109 (242,143 - 366,101) 2000 Modelled IHME
297,194 (242,658 - 369,065) 2001 Modelled IHME
297,189 (240,867 - 370,682) 2002 Modelled IHME
297,628 (239,155 - 374,450) 2003 Modelled IHME
299,046 (237,795 - 376,723) 2004 Modelled IHME
302,061 (238,592 - 384,668) 2005 Modelled IHME
307,647 (244,660 - 392,262) 2006 Modelled IHME
315,510 (254,407 - 399,587) 2007 Modelled IHME
324,307 (261,761 - 409,502) 2008 Modelled IHME
332,647 (266,895 - 417,063) 2009 Modelled IHME
339,139 (271,015 - 423,581) 2010 Modelled IHME
343,875 (275,669 - 430,041) 2011 Modelled IHME
347,983 (279,022 - 434,011) 2012 Modelled IHME
351,494 (280,985 - 439,703) 2013 Modelled IHME
354,455 (283,674 - 445,393) 2014 Modelled IHME
357,104 (284,365 - 446,113) 2015 Modelled IHME
356,881 (285,065 - 444,277) 2016 Modelled IHME
357,684 (282,905 - 450,501) 2017 Modelled IHME
362,555 (287,029 - 453,365) 2018 Modelled IHME
368,380 (288,926 - 466,027) 2019 Modelled IHME
230,000 (178,000 - 244,000) 2015 Modelled Blach et al, 2017
199,412 (145,585 - 210,403) 2016 Survey/reported The Kirby Institute, 2017
182,144 (128,845 - 192,981) 2017 Survey/reported The Kirby Institute, 2018
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.37 (5.29 - 7.31) 2019 Modelled IHME
6.4 (5.34 - 7.35) 2018 Modelled IHME
6.34 (5.31 - 7.27) 2017 Modelled IHME
6.38 (5.33 - 7.29) 2016 Modelled IHME
6.4 (5.41 - 7.36) 2015 Modelled IHME
6.26 (5.27 - 7.18) 2014 Modelled IHME
6.05 (5.12 - 6.92) 2013 Modelled IHME
5.84 (4.93 - 6.69) 2012 Modelled IHME
5.75 (4.85 - 6.60) 2011 Modelled IHME
5.59 (4.69 - 6.42) 2010 Modelled IHME
5.43 (4.55 - 6.22) 2009 Modelled IHME
5.28 (4.40 - 6.03) 2008 Modelled IHME
5.04 (4.23 - 5.77) 2007 Modelled IHME
4.82 (4.04 - 5.51) 2006 Modelled IHME
4.71 (3.97 - 5.40) 2005 Modelled IHME
4.65 (3.92 - 5.32) 2004 Modelled IHME
4.61 (3.87 - 5.26) 2003 Modelled IHME
4.51 (3.79 - 5.16) 2002 Modelled IHME
4.36 (3.67 - 4.99) 2001 Modelled IHME
4.28 (3.61 - 4.90) 2000 Modelled IHME
4.25 (3.59 - 4.84) 1999 Modelled IHME
4.23 (3.58 - 4.80) 1998 Modelled IHME
4.26 (3.60 - 4.84) 1997 Modelled IHME
4.24 (3.58 - 4.84) 1996 Modelled IHME
4.18 (3.54 - 4.77) 1995 Modelled IHME
4.18 (3.53 - 4.76) 1994 Modelled IHME
4.1 (3.47 - 4.68) 1993 Modelled IHME
4.1 (3.49 - 4.67) 1992 Modelled IHME
4.08 (3.46 - 4.66) 1991 Modelled IHME
4.12 (3.49 - 4.71) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,564 (1,301 - 1,797) 2019 Modelled IHME
1,552 (1,295 - 1,784) 2018 Modelled IHME
1,519 (1,271 - 1,740) 2017 Modelled IHME
1,506 (1,258 - 1,722) 2016 Modelled IHME
1,491 (1,259 - 1,713) 2015 Modelled IHME
1,437 (1,209 - 1,648) 2014 Modelled IHME
1,368 (1,157 - 1,565) 2013 Modelled IHME
1,301 (1,097 - 1,490) 2012 Modelled IHME
1,260 (1,063 - 1,446) 2011 Modelled IHME
1,206 (1,013 - 1,386) 2010 Modelled IHME
1,156 (968 - 1,323) 2009 Modelled IHME
1,106 (923 - 1,264) 2008 Modelled IHME
1,041 (874 - 1,192) 2007 Modelled IHME
981 (824 - 1,122) 2006 Modelled IHME
946 (798 - 1,084) 2005 Modelled IHME
921 (777 - 1,055) 2004 Modelled IHME
902 (758 - 1,029) 2003 Modelled IHME
872 (732 - 998) 2002 Modelled IHME
833 (701 - 953) 2001 Modelled IHME
809 (681 - 925) 2000 Modelled IHME
793 (670 - 904) 1999 Modelled IHME
780 (660 - 886) 1998 Modelled IHME
778 (657 - 885) 1997 Modelled IHME
767 (646 - 874) 1996 Modelled IHME
748 (632 - 854) 1995 Modelled IHME
740 (625 - 843) 1994 Modelled IHME
718 (608 - 820) 1993 Modelled IHME
709 (604 - 808) 1992 Modelled IHME
698 (591 - 796) 1991 Modelled IHME
695 (589 - 794) 1990 Modelled IHME
335 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
34 (25 - 43) 2019 Modelled IHME
34 (26 - 44) 2018 Modelled IHME
34 (26 - 44) 2017 Modelled IHME
34 (25 - 43) 2016 Modelled IHME
33 (25 - 42) 2015 Modelled IHME
33 (24 - 42) 2014 Modelled IHME
33 (24 - 41) 2013 Modelled IHME
33 (24 - 41) 2012 Modelled IHME
32 (24 - 41) 2011 Modelled IHME
32 (24 - 41) 2010 Modelled IHME
32 (24 - 41) 2009 Modelled IHME
32 (24 - 41) 2008 Modelled IHME
32 (24 - 40) 2007 Modelled IHME
32 (23 - 40) 2006 Modelled IHME
32 (23 - 40) 2005 Modelled IHME
32 (23 - 40) 2004 Modelled IHME
32 (23 - 40) 2003 Modelled IHME
32 (23 - 40) 2002 Modelled IHME
32 (23 - 40) 2001 Modelled IHME
31 (23 - 40) 2000 Modelled IHME
31 (23 - 40) 1999 Modelled IHME
31 (22 - 40) 1998 Modelled IHME
31 (23 - 40) 1997 Modelled IHME
31 (23 - 40) 1996 Modelled IHME
31 (23 - 40) 1995 Modelled IHME
31 (22 - 40) 1994 Modelled IHME
30 (22 - 39) 1993 Modelled IHME
30 (22 - 39) 1992 Modelled IHME
30 (22 - 39) 1991 Modelled IHME
30 (22 - 39) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
461 (364 - 631) 2016 Survey/reported Iversen J et al, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
41.8 (39.80 - 43.90) 2015 Survey/reported Memedovic S et al, 2016
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
HBV testing policy
Pregnant women, Risk-based
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
537
2019
(427 - 674)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,564
2019
(1,301 - 1,797)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
461
2016
(364 - 631)
Iversen J et al, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources